Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating a new release of the page or its underlying tooling. This update does not alter the visible study details.
    Difference
    0.0%
    Check dated 2026-09-15T23:57:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new investigator/location entry Tel Litwinsky, Israel was added, along with a new publication citation related to ATTR-CM attributes. A location entry Qiryat Krinitzi, Israel was removed.
    Difference
    0.1%
    Check dated 2026-09-08T22:30:04.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Qiryat Krinitzi, Israel was added to the study sites and Tel Litwinsky, Israel was removed. The page revision was updated to v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-01T20:21:56.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a funding note indicating a 2018 U.S. NIH grant/contract. Added a forthcoming publication citation for Pfister R et al., 'ACO-SWITCH: Rationale and Design of a Phase 4 Study Evaluating Serum Transthyretin in ATTR-CM After Switching from Tafamidis to Acoramidis' in Cardiol Ther, 2026 Aug 20.
    Difference
    0.1%
    Check dated 2026-08-25T20:20:22.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    An additional publication citation with a long author list and the plain-language summary of acoramidis was added to the Publications section. A new revision tag (Revision: v3.6.5) was introduced and the previous tag (Revision: v3.6.4) removed, reflecting an update to the study's documentation.
    Difference
    0.1%
    Check dated 2026-08-11T18:36:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a new publication citation to the Publications section for a 2026 JAMA Cardiology study that analyzes acoramidis (AG10) effects on heart failure-related health status in ATTR-CM. This external analysis expands the evidentiary context of the trial’s investigational drug.
    Difference
    0.0%
    Check dated 2026-08-04T15:50:43.000Z thumbnail image

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.